Research executive administration king Khalid medical city

The King Khalid Medical City Center for Health Research (KKMC-CHR) oversees the Human Research Protection (HRP) activities at KFSHD in order to ensure compliance with national and international research guidelines and best practices. In the oversight of all Human Research, KKMC-CHR follows the ethical principles outlined in the Principles of Islamic Jurisprudence and in the Belmont Report:
Respect for Persons
KFSHD’s Human Research Protection Program (HRPP) is a comprehensive system to ensure the protection of the rights and welfare of participants in Human Research. It is comprised of the KFSHD leadership, the Institutional Review Board (IRB), Quality Improvement Program (QIP), investigators and their study staff, and relevant departments.  The HRPP is based on all above-mentioned parties fulfilling their roles and responsibilities.
Since its inception in January 2010, Research Administration   has implemented the following initiatives: 
Hosting pharmaceutically sponsored clinical studies/trials 
Supporting researcher initiated studies from national and international universities.
Encouraging KFSH-D initiated research studies.
Protecting Human Subject through establishing the Institutional Review Board (IRB)
Promoting education and training for researchers through organizing educational events
Establishing a Human Subjects Education and Outreach program
Hosting and supporting student research projects (graduate, Masters and PhD)
The primary objective of the KKMC-CHR is to coordinate every aspect of clinical research, i. e.,  protocol development, protocol maintenance, data management, budget and grant preparation, contract development and management; audits, IRB submissions and study monitoring, post-study closure including publication. The department also conducts and supervises research related education and training activities and quality assurance activities. The Research Administration staff provides and enforces all necessary tools for conducting clinical research and survey studies in compliance with Good Clinical Practice (GCP) as well as national and international regulatory guidelines. All activities in KKMC-CHR are guided by its strategic Statements:
To improve patient care and outcomes through excellence in clinical and population health research
To be a leader in patient-centered translational research